BioNTech, Pfizer ask Europe to quickly approve virus vaccine

The German pharmaceutical company BioNTech and its U.S. partner Pfizer say they have submitted an application for speeded-up, conditional approval of their coronavirus vaccine with the European Medicines Agency.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/37uDmc2
via IFTTT